I Juhan, M F Calas, M Buonocore, P Mathieu, G Isnard, B Cazenave, A Serradimigni. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Blood Coagulation/drug effectsDrug Therapy, CombinationEndopeptidases/administration & dosageFibrin Fibrinogen Degradation ProductsFibrinogenHeparin/administration & dosageHeparin/therapeutic useHumansPhlebographyPlasminogenUrokinase-Type Plasminogen Activator/administration & dosageUrokinase-Type Plasminogen Activator/therapeutic usealpha 1-Antitrypsinalpha-2-Antiplasmin
Substances： See more » Fibrin Fibrinogen Degradation Productsalpha 1-Antitrypsinalpha-2-AntiplasminFibrinogenPlasminogenHeparinEndopeptidasesUrokinase-Type Plasminogen Activator
Year: 1979 PMID： 315625
Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249